Published in PLoS Pathog on November 11, 2010
Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol (2012) 2.65
The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties. Glycoconj J (2013) 0.99
Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines. Appl Environ Microbiol (2013) 0.96
Plant-made oral vaccines against human infectious diseases-Are we there yet? Plant Biotechnol J (2015) 0.96
The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates. PLoS One (2012) 0.95
Outer membrane vesicles induce immune responses to virulence proteins and protect against colonization by enterotoxigenic Escherichia coli. Clin Vaccine Immunol (2011) 0.95
Transepithelial antigen delivery in the small intestine: different paths, different outcomes. Curr Opin Gastroenterol (2013) 0.89
Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination. Immune Netw (2012) 0.88
Surface display of N-terminally anchored invasin by Lactobacillus plantarum activates NF-κB in monocytes. Appl Environ Microbiol (2012) 0.88
Use of lectin-functionalized particles for oral immunotherapy. Ther Deliv (2012) 0.85
Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Exp Mol Med (2014) 0.85
Enterocytes: active cells in tolerance to food and microbial antigens in the gut. Clin Exp Immunol (2012) 0.85
In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A. BMC Microbiol (2012) 0.84
The role of CD103⁺ dendritic cells in the intestinal mucosal immune system. Front Immunol (2011) 0.83
Immune Tolerance for Autoimmune Disease and Cell Transplantation. Annu Rev Biomed Eng (2016) 0.83
A mechanistic study on the destabilization of whole inactivated influenza virus vaccine in gastric environment. PLoS One (2013) 0.82
Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity. Nat Commun (2015) 0.82
Mucosal delivery of ACNPV baculovirus driving expression of the Gal-lectin LC3 fragment confers protection against amoebic liver abscess in hamster. Int J Biol Sci (2011) 0.80
Mucosal Lactobacillus vectored vaccines. Hum Vaccin Immunother (2013) 0.80
Plant-based oral vaccines against zoonotic and non-zoonotic diseases. Plant Biotechnol J (2016) 0.80
Mucosal vaccine delivery: Current state and a pediatric perspective. J Control Release (2016) 0.80
Roles of M cells in infection and mucosal vaccines. Hum Vaccin Immunother (2014) 0.79
Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation. Biomacromolecules (2014) 0.78
Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation. J Control Release (2015) 0.77
Loss of sialic acid binding domain redirects protein σ1 to enhance M cell-directed vaccination. PLoS One (2012) 0.76
Screening of surface markers on rat intestinal mucosa microfold cells by using laser capture microdissection combined with protein chip technology. Int J Clin Exp Med (2014) 0.75
The osmotic stress response of split influenza vaccine particles in an acidic environment. Arch Pharm Res (2013) 0.75
Formulation and delivery of vaccines: Ongoing challenges for animal management. J Pharm Bioallied Sci (2012) 0.75
Targeted Delivery of VP1 Antigen of Foot-and-mouth Disease Virus to M Cells Enhances the Antigen-specific Systemic and Mucosal Immune Response. Immune Netw (2013) 0.75
Mechanisms Underlying the Immune Response Generated by an Oral Vibrio cholerae Vaccine. Int J Mol Sci (2016) 0.75
Cellobiose-coated poly(lactide-co-glycolide) particles loaded with diphtheria toxoid for per os immunization. Croat Med J (2015) 0.75
Mucosal immunity and vaccines. Nat Med (2005) 5.44
The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol (1987) 5.30
Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med (2004) 4.10
The mucosal immune system: from fundamental concepts to vaccine development. Vaccine (1992) 3.99
Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology (1974) 3.97
Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science (1997) 3.65
Oral tolerance. Immunol Rev (2005) 3.48
Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature (2009) 3.18
Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell Microbiol (1999) 3.17
Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci U S A (2004) 2.75
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol (2008) 2.58
Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect Immun (1994) 2.56
Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun (1997) 2.49
Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science (1995) 2.44
Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity (1994) 2.39
Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis (2000) 2.37
M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect Immun (1998) 2.34
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med (2001) 2.27
Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun (1997) 2.05
Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol (2005) 1.90
Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. PLoS One (2009) 1.82
Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol (2002) 1.76
Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int J Food Microbiol (1998) 1.76
Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med (1996) 1.75
Seasonal influenza vaccines. Curr Top Microbiol Immunol (2009) 1.63
Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine (1990) 1.62
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc Natl Acad Sci U S A (2004) 1.60
Comprehensive gene expression profiling of Peyer's patch M cells, villous M-like cells, and intestinal epithelial cells. J Immunol (2008) 1.58
Immunologic uniqueness of the genital tract: challenge for vaccine development. Am J Reprod Immunol (2005) 1.54
Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci U S A (2007) 1.51
Proteolysis and class I major histocompatibility complex antigen presentation. Immunol Rev (1999) 1.47
Oxidation-specific epitopes are important targets of innate immunity. J Intern Med (2008) 1.41
Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. J Immunol (1999) 1.37
Plants for delivery of edible vaccines. Curr Opin Biotechnol (2000) 1.34
Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J Immunol (2004) 1.31
Perspectives on mucosal vaccines: is mucosal tolerance a barrier? J Immunol (2007) 1.28
Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle. Infect Immun (1999) 1.18
Expression of specific markers and particle transport in a new human intestinal M-cell model. Biochem Biophys Res Commun (2000) 1.18
Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol (2004) 1.12
A comparison of antibody titres in mouse uterine fluid after immunization by several routes, and the effect of the uterus on antibody titres in vaginal fluid. J Reprod Fertil (1990) 1.11
Cell activation by synthetic lipopeptides of the hepatitis C virus (HCV)--core protein is mediated by toll like receptors (TLRs) 2 and 4. Immunol Lett (2002) 1.11
Mucosal vaccines: novel advances in technology and delivery. Expert Rev Vaccines (2009) 1.09
The development of M cells in Peyer's patches is restricted to specialized dome-associated crypts. Am J Pathol (1999) 1.08
Oral immunization: an update. Curr Opin Gastroenterol (2008) 1.06
Enteric vaccines for the developing world: a challenge for mucosal immunology. Mucosal Immunol (2009) 1.05
Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi. Infect Immun (2007) 1.05
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. Drug Discov Today (2005) 1.03
Induction of beta-defensin 3 in keratinocytes stimulated by bacterial lipopeptides through toll-like receptor 2. Microbes Infect (2006) 1.01
Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection. Vaccine (2009) 1.01
Up-regulation of microsphere transport across the follicle-associated epithelium of Peyer's patch by exposure to Streptococcus pneumoniae R36a. FASEB J (1999) 1.01
Human intestinal M cells display the sialyl Lewis A antigen. Infect Immun (1999) 1.01
DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication. Virology (2005) 0.96
Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses. Immunol Cell Biol (2010) 0.96
In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli. Vaccine (2009) 0.95
M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J Drug Target (2007) 0.95
The role of M cells in mucosal immunity. Cell Mol Life Sci (2000) 0.95
M cell-targeted delivery of vaccines and therapeutics. Expert Opin Drug Deliv (2008) 0.94
Intranasal immunization with a recombinant truncated FimH adhesin adjuvanted with CpG oligodeoxynucleotides protects mice against uropathogenic Escherichia coli challenge. Can J Microbiol (2006) 0.94
Oral adenoviral-based vaccines: historical perspective and future opportunity. Expert Rev Vaccines (2008) 0.93
A cocktail of Mycobacterium bovis BCG recombinants expressing the SIV Nef, Env, and Gag antigens induces antibody and cytotoxic responses in mice vaccinated by different mucosal routes. AIDS Res Hum Retroviruses (1998) 0.93
A region of the Yersinia pseudotuberculosis invasin protein that contributes to high affinity binding to integrin receptors. J Biol Chem (1996) 0.92
Oestradiol regulation of antigen presentation by uterine stromal cells: role of transforming growth factor-beta production by epithelial cells in mediating antigen-presenting cell function. Immunology (2003) 0.92
Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium. Vaccine (2008) 0.92
M cells at locations outside the gut. Semin Immunol (1999) 0.92
Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin. Vaccine (2004) 0.91
M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens. Infect Immun (2009) 0.91
Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells. Vaccine (2009) 0.91
Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques. J Med Virol (2004) 0.91
Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine (2003) 0.91
A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity. J Immunol (2009) 0.91
Mucosal immunity to vaccines: current concepts for vaccine development and immune response analysis. Adv Exp Med Biol (1992) 0.91
Transgene vaccination using Ulex europaeus agglutinin I (UEA-1) for targeted mucosal immunization against HIV-1 envelope. Vaccine (2005) 0.90
Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits. Colloids Surf B Biointerfaces (2009) 0.89
Mucosal immunogenicity of plant lectins in mice. Immunology (2000) 0.88
Bell's palsy and parenteral inactivated influenza vaccine. Hum Vaccin (2006) 0.87
Mucosal HIV vaccines: a holy grail or a dud? Vaccine (2010) 0.87
Induction of broad cross-subtype-specific HIV-1 immune responses by a novel multivalent HIV-1 peptide vaccine in cynomolgus macaques. J Immunol (2008) 0.87
Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization. J Immunol Methods (1998) 0.85
Induction of T helper cells and cytokines for mucosal IgA responses. Adv Exp Med Biol (1992) 0.85
Validation and quantitation of an in vitro M-cell model. Biochem Biophys Res Commun (2002) 0.84
Activation and regulation of toll-like receptor 9: CpGs and beyond. Mini Rev Med Chem (2008) 0.83
Plant-based vaccines for animal health. Rev Sci Tech (2005) 0.83
Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles. Eur J Pharm Sci (2007) 0.83
Targeted delivery of immunogen to primate m cells with tetragalloyl lysine dendrimer. J Immunol (2009) 0.83
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects. Vaccine (2001) 0.82
Caveolae-mediated entry of Salmonella typhimurium in a human M-cell model. Biochem Biophys Res Commun (2009) 0.82
Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein. Vaccine (2009) 0.82
Uptake of amplifiable fragments of retrotransposon DNA from the human alimentary tract. Mol Genet Genomics (2003) 0.81
Role of the polypeptide region of a 33kDa mycobacterial lipoprotein for efficient IL-12 production. Cell Immunol (2004) 0.81
Viral peptide immunogens: current challenges and opportunities. J Pept Sci (2007) 0.81
Plant-based oral vaccines: results of human trials. Curr Top Microbiol Immunol (2009) 0.80
The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action. Eur J Immunol (1999) 0.80
Development of oral vaccines for human use. Curr Opin Mol Ther (2000) 0.80
Mucosal vaccination against bacterial respiratory infections. Expert Rev Vaccines (2008) 0.80
The activity of lipopeptide TLR2 agonists critically depends on the presence of solubilizers. Eur J Immunol (2007) 0.79
[The mechanisms of antigen uptake in the small and large intestines: the roll of the M cells for the initiation of immune responses]. Z Gastroenterol (2000) 0.78
Delivery of plant-derived vaccines. Expert Opin Drug Deliv (2005) 0.77
Flavoridin inhibits Yersinia enterocolitica uptake into fibronectin-adherent HeLa cells. FEMS Microbiol Lett (2005) 0.76
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials. Lancet Oncol (2015) 4.84
Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat Med (2002) 3.04
Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol (2005) 2.85
New vision for Revised National Tuberculosis Control Programme (RNTCP): Universal access - "reaching the un-reached". Indian J Med Res (2012) 2.83
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest (2009) 2.82
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood (2007) 2.76
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. J Cell Biol (2010) 2.47
The pathophysiology of IgA nephropathy. J Am Soc Nephrol (2011) 2.27
Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis. Mol Ther (2005) 2.27
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest (2008) 2.15
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int (2005) 2.08
Investigation of optimizing and translating pH-sensitive pulsed-chemical exchange saturation transfer (CEST) imaging to a 3T clinical scanner. Magn Reson Med (2008) 2.01
Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev (2009) 1.95
Morphological changes in bile ducts following preoperative biliary stenting. Indian J Gastroenterol (2003) 1.94
Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J Nucleic Acids (2010) 1.91
Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int (2002) 1.88
Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med (Berl) (2008) 1.86
Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff's bases. Bioorg Med Chem (2006) 1.81
Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron (2012) 1.78
Low-level laser therapy: a useful technique for enhancing the proliferation of various cultured cells. Lasers Med Sci (2011) 1.76
Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol (2008) 1.76
Extrahepatic portal venous obstruction and obstructive jaundice: approach to management. J Gastroenterol Hepatol (2005) 1.73
AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEbeta mutation. Invest Ophthalmol Vis Sci (2008) 1.68
A prospective, partially randomized study of pregnancy outcomes and hematologic responses to oral and intramuscular iron treatment in moderately anemic pregnant women. Am J Clin Nutr (2004) 1.68
IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol (2008) 1.64
The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets (2009) 1.64
Probiotic Lactobacillus rhamnosus GG and Aloe vera gel improve lipid profiles in hypercholesterolemic rats. Nutrition (2013) 1.61
The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. J Cell Biol (2010) 1.61
TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J (2007) 1.60
Mucosal immunoglobulins. Immunol Rev (2005) 1.60
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. J Biol Chem (2006) 1.55
Wound-induced ATP release and EGF receptor activation in epithelial cells. J Cell Sci (2007) 1.54
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins. Virology (2006) 1.51
Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol (2010) 1.50
Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry. J Biol Chem (2005) 1.50
Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. J Biol Chem (2010) 1.48
Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety. Bioorg Med Chem Lett (2007) 1.46
Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. Mol Immunol (2007) 1.45
Alpha 1 antitrypsin deficiency in children with chronic liver disease in North India. Indian Pediatr (2009) 1.44
Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Hum Mol Genet (2009) 1.44
Usefulness of anti -CCP antibodies in rheumatic diseases in Indian patients. Indian J Med Sci (2009) 1.43
Modified needle drainage. A safe and efficient technique of subretinal fluid drainage in scleral buckling procedure. Indian J Ophthalmol (2004) 1.42
Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS. J Pharm Biomed Anal (2006) 1.38
Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy. Anal Bioanal Chem (2007) 1.37
Tuberculosis management practices by private practitioners in Andhra Pradesh, India. PLoS One (2013) 1.33
Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis (2004) 1.33
Humoral immune responses to microbial infections in the genital tract. Microbes Infect (2002) 1.32
Soft tissue cysticercosis - Ultrasonographic spectrum of the disease. Indian J Radiol Imaging (2011) 1.29
Dlk1 is necessary for proper skeletal muscle development and regeneration. PLoS One (2010) 1.28
Skin tissue engineering for tissue repair and regeneration. Tissue Eng Part B Rev (2008) 1.27
Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire. J Virol (2007) 1.26
Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells. Immunology (2006) 1.24
Intracellular redox state alters NMDA receptor response during aging through Ca2+/calmodulin-dependent protein kinase II. J Neurosci (2010) 1.24
Surgical management of corrosive strictures of stomach. Indian J Gastroenterol (2004) 1.24
Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch. J Cell Physiol (2006) 1.24
Interaction of age and chronic estradiol replacement on memory and markers of brain aging. Neurobiol Aging (2003) 1.23
Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice. PLoS One (2010) 1.22
Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation. Mol Cell Proteomics (2010) 1.21
Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS Res Hum Retroviruses (2002) 1.21
Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead. Indian J Med Res (2013) 1.21
Prevalence of dental caries and treatment needs amongst the school children of three educational zones of urban Delhi, India. Indian J Dent Res (2011) 1.20
Feasibility and effectiveness of provider initiated HIV testing and counseling of TB suspects in Vizianagaram district, South India. PLoS One (2012) 1.20
Cancer-preventing attributes of probiotics: an update. Int J Food Sci Nutr (2010) 1.20
State and socio-demographic group variation in out-of-pocket expenditure, borrowings and Janani Suraksha Yojana (JSY) programme use for birth deliveries in India. BMC Public Health (2012) 1.20
TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy. Exp Diabetes Res (2012) 1.19
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Three-year follow-up of protection rates in children given varicella vaccine. Can J Infect Dis (2002) 1.19
Estrogen effects on cognition and hippocampal transcription in middle-aged mice. Neurobiol Aging (2007) 1.19
Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis (2005) 1.18
Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals. AIDS (2005) 1.18
Magnetic switching of ferroelectric domains at room temperature in multiferroic PZTFT. Nat Commun (2013) 1.18
Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem (2002) 1.18
Mirizzi syndrome and gallbladder cancer. J Hepatobiliary Pancreat Surg (2006) 1.18
IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib Nephrol (2007) 1.17
Chemical profile, antifungal, antiaflatoxigenic and antioxidant activity of Citrus maxima Burm. and Citrus sinensis (L.) Osbeck essential oils and their cyclic monoterpene, DL-limonene. Food Chem Toxicol (2010) 1.17
Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res (2012) 1.17
Case report: Endotracheal tube malposition in a patient with a tracheal bronchus. Can J Anaesth (2006) 1.16
Signaling mechanisms in mammalian myoblast fusion. Sci Signal (2013) 1.15
HIV infection: first battle decides the war. Trends Immunol (2006) 1.15
IL-10 regulation by HIV-Tat in primary human monocytic cells: involvement of calmodulin/calmodulin-dependent protein kinase-activated p38 MAPK and Sp-1 and CREB-1 transcription factors. J Immunol (2007) 1.15
Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide. J Immunol (2010) 1.15
Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol (2007) 1.14
TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1. J Immunol (2009) 1.14
Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice. Am J Pathol (2010) 1.13
Haemorrhagic complications of pancreaticoduodenectomy. ANZ J Surg (2004) 1.13
Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway. J Biol Chem (2007) 1.12
"Ambulatory PCNL" (tubeless PCNL under regional anesthesia) -- a preliminary report of 10 cases. Int Urol Nephrol (2005) 1.11
Synthesis, anti-inflammatory and analgesic activities evaluation of some mono, bi and tricyclic pyrimidine derivatives. Bioorg Med Chem (2005) 1.11
Human male genital tract secretions: both mucosal and systemic immune compartments contribute to the humoral immunity. J Immunol (2005) 1.11
Innate immune responses in hepatitis B virus (HBV) infection. Virol J (2014) 1.11
MTHFR C677T and A1298C polymorphisms are risk factors for Down's syndrome in Indian mothers. J Hum Genet (2006) 1.11
Ponseti's manipulation in neglected clubfoot in children more than 7 years of age: a prospective evaluation of 25 feet with long-term follow-up. J Pediatr Orthop B (2010) 1.10
The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms. Mol Cell Biol (2012) 1.10
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. Am J Cardiol (2003) 1.09
IgA-containing immune complexes in the urine of IgA nephropathy patients. Nephrol Dial Transplant (2006) 1.09